Skip to main content
. 2022 Oct 10;49(5):e227920. doi: 10.14503/THIJ-22-7920

Fig. 1.

Fig. 1

Illustration presents contemporary guideline-directed medical therapies (GDMTs) for A) heart failure with reduced ejection fraction (HFrEF) and B) heart failure with preserved ejection fraction (HFpEF).

ARNI, angiotensin receptor neprilysin inhibitor; MRA, mineralocorticoid receptor antagonist; SGLT2i, sodium-glucose cotransporter 2 inhibitor